Type2 Diabetes MellitusNCT03088475
A Nurse-led Smartphone-based Self-management Programme for Type 2 Diabetes Patients With Poor Blood Glucose Control
A study testing nurse-led smartphone-based self-management programme and exiting nurse-led diabetes service in people with Type2 Diabetes Mellitus, run by National University of Singapore.
Trial summary
Aim. To develop and compare a nurse-led smartphone-based self-management programme with an existing nurse-led diabetes service on health-related outcomes of type 2 diabetes patients with poor glycaemic control in Singapore. Background. Read more about this study
- Who is it for?
- Ages 21 years and older
- Conditions the study is for
- Type2 Diabetes Mellitus
- What is being tested?
- nurse-led smartphone-based self-management programme and exiting nurse-led diabetes service
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 128 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 2018to 30 Dec 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- have confirmed medical diagnosis of type 2 DM;
- are 21 years old and above;
- have blood test result of HbA1c > 8% in the most recent test indicating poor glycemic control;
- possess and able to use smart mobile phone (e.g. Samsung Galaxy, iPhone) in their daily lives; and
- are able to speak and read English or Chinese.
Who cannot join
- have suffered severe complications such as severe stroke, visual impairment, renal failure that interfere with self-care activities;
- have known history of major psychiatric illness;
- have reading and hearing difficulties.
Trial locations and contacts
No sites are listed yet.
About this study
Official title: A Randomised Controlled Trial on a Nurse-led Smartphone-based Self-management Programme for Type 2 Diabetes Patients With Poor Glycaemic Control
Aim. To develop and compare a nurse-led smartphone-based self-management programme with an existing nurse-led diabetes service on health-related outcomes of type 2 diabetes patients with poor glycaemic control in Singapore.
Background. Over the past decades, Asia has emerged as the 'diabetes epicentre' in the world due to rapid economic development, urbanisation, and nutrition transition. There is an urgent need to develop more effective care management strategies in response to this rising diabetes epidemic.
Read more
Design. A randomised controlled trial with pre- and repeated post-tests control group design.
Methodology. A total of 128 type 2 diabetes patients with poor glycaemic control will be recruited from the diabetes clinic of a public acute hospital in Singapore through convenience sampling. Study participants will be randomly allocated either to the experimental group or the control group. Outcome measures will include the 10-item General Self-Efficacy Scale, 11-item Revised Summary of Diabetes Self-care Activities, and 19-item Diabetes-Dependent Quality of Life. Data will be collected at three time points: baseline, 3 months, and 6 months from the baseline.
Discussion. It is expected that this programme will be an alternative offered to diabetes patients to master their self-care management skills, in addition to the existing diabetes service provided in diabetes clinics in Singapore hospitals. Furthermore, the self-supporting and less resource-intensive nature of this programme, through the use of a smartphone application as the mode of intervention delivery, will greatly reduce nurses' direct contact time with patients and allow more time to be allocated to those who require more attention.
Read the detailed description
Specific Aims
The aims of this study are:
- to develop a nurse-led smartphone-based self-management programme (NSSMP) for patients with type 2 diabetes;
- to compare the NSSMP with an existing nurse-led diabetes service (NDS) on self-efficacy, diabetes self-care activities, health-related quality of life (HRQoL), glycaemic control, acute diabetes complications (e.g. hypoglycaemia, Diabetic Ketoacidosis [DKA] and Hyperosmolar Hyperglycemic Syndrome [HHS]), and health-service use among type 2 diabetes patients with poor glycemic control in Singapore.
Study Hypotheses
Study participants will be randomized into an existing NDS group (i.e. control group) and a newly developed NSSMP group (i.e. experimental group). It is hypothesized that participants in the NSSMP group as compared with participants in the NDS group will have significantly:
- Higher level of self-efficacy;
- Increased level of diabetes self-care activities;
- More positive perceived health-related quality of life;
- Reduced glycosylated haemoglobin (HbA1c) and acute diabetes complications (e.g. hypoglycaemia, Diabetic Ketoacidosis [DKA] and Hyperosmolar Hyperglycemic Syndrome [HHS] ); and
- Reduced usage of health services (e.g. diabetes-related hospital readmission, emergency room attendance, and unplanned medical consultation).
Approach Adopted in This Study Development of NSSMP: A nurse-led smartphone-based self-management programme, or NSSMP for short, will be developed by the study team. The model of self-efficacy will be used to guide the development of the NSSMP to ensure it would be theoretically sound and empirically tested. The NSSMP is a 6-month programme comprising an individual education session, and a newly developed smartphone App as a self-help education resource. The NSSMP involves the use of a smartphone, internet, and communication technologies to assist patients to manage their disease at homes or wherever they are. Patient's health data will be monitored by their smartphones. All the data will be synchronized to a web-connected portal on a remote server. The nurse would be able to access the participant's data (e.g. blood glucose, exercise, blood pressure, body weight, diet) through the web-connected portal so that the individualized care and consultation could be rendered through the tele or video conference.
Study design, setting and participants: A randomized controlled trial with a pre- and repeated post-test control group design is adopted. A convenience sample of 128 type 2 DM patients with poor glycemic control will be recruited from the Diabetes Clinic of National University Hospital (NUH). Study participants will be randomly assigned either to a 6-month NSSMP group (i.e experimental group) or the NDS group (i.e. control group). The existing NDS for DM patients in the NUH consists of face-to-face patient education sessions plus telephone follow-ups. The patients are required to return back to the Diabetes Clinic to attend the educations sessions based on the scheduled appointment. They are instructed to measure blood glucose at home and modes of contact (voicemail, fax and email address) are given for reporting the glucose readings weekly. If the patient does not report, the nurse will have to make calls or send SMS message to the patient to follow up their blood glucose results. The nurses would then provide telephone counselling services to the patients where needed based on the blood glucose results, and sometime would request patients coming back to the Diabetes Clinic to see the doctors and the diabetes advanced practice nurses.
Outcome measures: Study outcome measures include the 10-item General Self-Efficacy Scale, 11-item Revised Summary of Diabetes Self-care Activities, and 19-item Diabetes-Dependent Quality of Life which will be used to measure self-efficacy, level of diabetes self-care activities, and health-related quality of life of the participants respectively. The participant's socio-demographic and clinical data (e.g. HbA1c, acute diabetes complications, and lipid level) will be also collected. Data will be collected at 3 time points: baseline (i.e. pre-test), 3 months from baseline (post-test 1), and 6 months from the baseline (post-test 2). The health service use (e.g. diabetes-related hospital readmission, emergency room attendance, and unplanned medical consultation) will be also assessed at the 6th month of the end of the programme.
Data analysis: The IBM SPSS 23.0 will be used for data entry and analysis. Intention-to-treat will be adopted in data analysis. Repeated measures analysis of covariance will be used to examine the differences between, within, and the interaction (group x time) effects on each continuous outcome. Confounding variables (e.g. age), will be controlled as covariate in the analysis. The Chi-squared test or Fisher's exact test will be used to test the difference of the incidence of acute diabetes complications and the numbers of health service use between the two groups. All statistical tests will be two-tailed, and a p < 0.05 is used to indicate statistical significance.
Study Significance If the NSSMP is demonstrated to be effective in this study, a smartphone App developed in this project can be provided to all DM patients and their family members/caregivers as a self-help education resource at home. It will provide and equip knowledge to the patient and their family members/caregivers to enhance their knowledge and skills in management of diabetes so as to achieve the expected patient outcomes in improving self-efficacy, diabetes self-care activities, HRQoL, and clinical outcomes. It is expected that this programme will be an option that can be offered to diabetes patients to master their self-care management skills in addition to the existing diabetes service provided in diabetes clinics in Singapore hospitals where patients with poorly controlled condition are being monitored. In addition, the independent nature of this programme with application of technology will greatly reduce nurses' contact time with patients which accord them more time for those who require more time, for example, those afflicted with diabetes-related complications. This will result in a more efficient use of healthcare resources in the long run. Eventually, this programme will be available for all diabetes patients living in the community.
Feasibility of the Study The research team comprises experienced researchers from different disciplines. The PI has extensive research experience in the area of chronic diseases management and mHealth intervention. Two Co-Is are practised clinicians in diabetes care, they will facilitate the access to potential study participants and oversee the implementation of the project. One Co-I has the expertise in biomedical engineering, mobile App development, and information management. He and his team will be in charge of developing the system. In addition, the preliminary integrative literature review and qualitative patient interviews were performed to inform the development of the content for the mobile app. Through harnessing the technology, the smartphone App based platform can be established to reduce the contact time with patients for the healthcare providers.
- Conditions
- Type2 Diabetes Mellitus
- Being tested
- nurse-led smartphone-based self-management programme, exiting nurse-led diabetes service
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
nurse-led smartphone-based self-management programmeBehavioural
The participants in the experimental group will undergo nurse-led smartphone-based self-management programme (NSSMP), a 6-month programme comprising an individual education session, and a newly developed smartphone App as a self-help education resource
exiting nurse-led diabetes serviceBehavioural
the patients in the control group will receive the exiting nurse-led diabetes service (i.e. NDS) provided by the hospital
| Study group | Role | What they receive |
|---|---|---|
| Experimental Group | Experimental | A six-month nurse-led smartphone-based self-management programme (i.e. NSSMP) will be provided to the participants in the experimental group. Receives: Behavioral: nurse-led smartphone-based self-management programme |
| Control Group | Active comparator | the patients in the control group will receive the exiting nurse-led diabetes service (i.e. NDS) provided by the hospital Receives: Behavioral: exiting nurse-led diabetes service |
What is being measured
The primary outcome is the main question the study is designed to answer.
Self-efficacy: change is being assessed
Self-efficacy will be assessed using the General Self-efficacy Scale (GSS), a 10-item questionnaire of the unidimensional measure of one's competence to deal with the challenging events encountered in various life situations
Measured: Change from baseline self-efficacy at 6 months
Secondary outcomes (9)
Diabetes self-care activities: change is being assessed
Diabetes self-care activities will be measured using the 11-item Revised Summary of Diabetes Self-care Activities (RSDSCA)
Measured: Change from baseline diabetes self-care acitivities at 6 months
Health-related Quality of Life: change is being assessed
Health-related Quality of Life will be measured using the 19-item Diabetes-Dependent Quality of Life (DDQoL)
Measured: Change from baseline health-related quality of life at 6 months
Acute Diabetes Complications: change is being assessed
the number of frequency of acute diabetes complications including hypoglycaemia, DKA and HHS will be collected
Measured: Change from baseline acute diabetes complications at 6 months
HbA1c: change is being assessed
HbA1c will be obtained from patient's medical record
Measured: Change from baseline HbA1c at 6 months
Smoking status: change is being assessed
Smoking status will reported by the participant.
Measured: Change from baseline smoking status at 6 months
Alcohol consumption: change is being assessed
Alcohol consumption will be reported by the participant
Measured: Change from baseline alcohol consumption at 6 months
Diabetes-related hospital admission
number of diabetes-related hospital admission will be recorded
Measured: at the 6-month of the study period
Visits to the emergency
number of diabetes-related emergency department visit will be recorded
Measured: at the 6-month of the study period
Unplanned medical consultation
number of unplanned medical consultation due to diabetes problems will be recorded
Measured: at the 6-month of the study period
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Mar 2017
- Study start1 Jan 2018 (estimated)
- Primary completion30 Jun 2019 (estimated)
- Study completion30 Dec 2019 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Type2 Diabetes MellitusStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 128 participants (estimated)
Sponsor and investigators
- Lead sponsor
- National University of Singapore
- Sponsor type
- University, hospital or other
- Collaborators
- National University Hospital, Singapore
- Responsible party
- Principal investigator, Wang Wenru, National University of Singapore
- Investigators
- Wenru P Wang, PhD, Principal investigator, National University of Singapore
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03088475
- Sponsor's protocol ID
- AcRFTier1FRCT1-2016APR-02
- Status last verified
- Mar 2017
- First submitted
- 13 Mar 2017
- Last updated
- 23 Mar 2017
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Jiang Y, Ramachandran HJ, Teo JYC, Leong FL, Lim ST, Nguyen HD, Wang W. Effectiveness of a nurse-led smartphone-based self-management programme for people with poorly controlled type 2 diabetes: A randomized controlled trial. J Adv Nurs. 2022 Apr;78(4):1154-1165. doi: 10.1111/jan.15178. Epub 2022 Feb 15.
PubMed 35170786Wang W, Seah B, Jiang Y, Lopez V, Tan C, Lim ST, Ren H, Khoo YH. A randomized controlled trial on a nurse-led smartphone-based self-management programme for people with poorly controlled type 2 diabetes: A study protocol. J Adv Nurs. 2018 Jan;74(1):190-200. doi: 10.1111/jan.13394. Epub 2017 Aug 17.
PubMed 28727183
Study at a glance
From the registry record, last updated by the sponsor on 23 Mar 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Randomised Controlled Trial on a Nurse-led Smartphone-based Self-management Programme for Type 2 Diabetes Patients With Poor Glycaemic Control
- ClinicalTrials.gov ID
- NCT03088475
- Acronym / sponsor ID
- AcRFTier1FRCT1-2016APR-02
- Conditions
- Type2 Diabetes Mellitus
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 128 participants (estimated)
- Lead sponsor
- National University of SingaporeUniversity, hospital or other
- Collaborators
- National University Hospital, Singapore
- Study start
- 1 Jan 2018 (estimated)
- Primary completion
- 30 Jun 2019 (estimated)
- Study completion
- 30 Dec 2019 (estimated)
- First posted
- 23 Mar 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Aim. To develop and compare a nurse-led smartphone-based self-management programme with an existing nurse-led diabetes service on health-related outcomes of type 2 diabetes patients with poor glycaemic control in Singapore.
Background. Over the past decades, Asia has emerged as the 'diabetes epicentre' in the world due to rapid economic development, urbanisation, and nutrition transition. There is an urgent need to develop more effective care management strategies in response to this rising diabetes epidemic.
Design. A randomised controlled trial with pre- and repeated post-tests control group design.
Methodology. A total of 128 type 2 diabetes patients with poor glycaemic control will be recruited from the diabetes clinic of a public acute hospital in Singapore through convenience sampling. Study participants will be randomly allocated either to the experimental group or the control group. Outcome measures will include the 10-item General Self-Efficacy Scale, 11-item Revised Summary of Diabetes Self-care Activities, and 19-item Diabetes-Dependent Quality of Life. Data will be collected at three time points: baseline, 3 months, and 6 months from the baseline.
Discussion. It is expected that this programme will be an alternative offered to diabetes patients to master their self-care management skills, in addition to the existing diabetes service provided in diabetes clinics in Singapore hospitals. Furthermore, the self-supporting and less resource-intensive nature of this programme, through the use of a smartphone application as the mode of intervention delivery, will greatly reduce nurses' direct contact time with patients and allow more time to be allocated to those who require more attention.
Detailed description
Specific Aims
The aims of this study are:
- to develop a nurse-led smartphone-based self-management programme (NSSMP) for patients with type 2 diabetes;
- to compare the NSSMP with an existing nurse-led diabetes service (NDS) on self-efficacy, diabetes self-care activities, health-related quality of life (HRQoL), glycaemic control, acute diabetes complications (e.g. hypoglycaemia, Diabetic Ketoacidosis [DKA] and Hyperosmolar Hyperglycemic Syndrome [HHS]), and health-service use among type 2 diabetes patients with poor glycemic control in Singapore.
Study Hypotheses
Study participants will be randomized into an existing NDS group (i.e. control group) and a newly developed NSSMP group (i.e. experimental group). It is hypothesized that participants in the NSSMP group as compared with participants in the NDS group will have significantly:
- Higher level of self-efficacy;
- Increased level of diabetes self-care activities;
- More positive perceived health-related quality of life;
- Reduced glycosylated haemoglobin (HbA1c) and acute diabetes complications (e.g. hypoglycaemia, Diabetic Ketoacidosis [DKA] and Hyperosmolar Hyperglycemic Syndrome [HHS] ); and
- Reduced usage of health services (e.g. diabetes-related hospital readmission, emergency room attendance, and unplanned medical consultation).
Approach Adopted in This Study Development of NSSMP: A nurse-led smartphone-based self-management programme, or NSSMP for short, will be developed by the study team. The model of self-efficacy will be used to guide the development of the NSSMP to ensure it would be theoretically sound and empirically tested. The NSSMP is a 6-month programme comprising an individual education session, and a newly developed smartphone App as a self-help education resource. The NSSMP involves the use of a smartphone, internet, and communication technologies to assist patients to manage their disease at homes or wherever they are. Patient's health data will be monitored by their smartphones. All the data will be synchronized to a web-connected portal on a remote server. The nurse would be able to access the participant's data (e.g. blood glucose, exercise, blood pressure, body weight, diet) through the web-connected portal so that the individualized care and consultation could be rendered through the tele or video conference.
Study design, setting and participants: A randomized controlled trial with a pre- and repeated post-test control group design is adopted. A convenience sample of 128 type 2 DM patients with poor glycemic control will be recruited from the Diabetes Clinic of National University Hospital (NUH). Study participants will be randomly assigned either to a 6-month NSSMP group (i.e experimental group) or the NDS group (i.e. control group). The existing NDS for DM patients in the NUH consists of face-to-face patient education sessions plus telephone follow-ups. The patients are required to return back to the Diabetes Clinic to attend the educations sessions based on the scheduled appointment. They are instructed to measure blood glucose at home and modes of contact (voicemail, fax and email address) are given for reporting the glucose readings weekly. If the patient does not report, the nurse will have to make calls or send SMS message to the patient to follow up their blood glucose results. The nurses would then provide telephone counselling services to the patients where needed based on the blood glucose results, and sometime would request patients coming back to the Diabetes Clinic to see the doctors and the diabetes advanced practice nurses.
Outcome measures: Study outcome measures include the 10-item General Self-Efficacy Scale, 11-item Revised Summary of Diabetes Self-care Activities, and 19-item Diabetes-Dependent Quality of Life which will be used to measure self-efficacy, level of diabetes self-care activities, and health-related quality of life of the participants respectively. The participant's socio-demographic and clinical data (e.g. HbA1c, acute diabetes complications, and lipid level) will be also collected. Data will be collected at 3 time points: baseline (i.e. pre-test), 3 months from baseline (post-test 1), and 6 months from the baseline (post-test 2). The health service use (e.g. diabetes-related hospital readmission, emergency room attendance, and unplanned medical consultation) will be also assessed at the 6th month of the end of the programme.
Data analysis: The IBM SPSS 23.0 will be used for data entry and analysis. Intention-to-treat will be adopted in data analysis. Repeated measures analysis of covariance will be used to examine the differences between, within, and the interaction (group x time) effects on each continuous outcome. Confounding variables (e.g. age), will be controlled as covariate in the analysis. The Chi-squared test or Fisher's exact test will be used to test the difference of the incidence of acute diabetes complications and the numbers of health service use between the two groups. All statistical tests will be two-tailed, and a p < 0.05 is used to indicate statistical significance.
Study Significance If the NSSMP is demonstrated to be effective in this study, a smartphone App developed in this project can be provided to all DM patients and their family members/caregivers as a self-help education resource at home. It will provide and equip knowledge to the patient and their family members/caregivers to enhance their knowledge and skills in management of diabetes so as to achieve the expected patient outcomes in improving self-efficacy, diabetes self-care activities, HRQoL, and clinical outcomes. It is expected that this programme will be an option that can be offered to diabetes patients to master their self-care management skills in addition to the existing diabetes service provided in diabetes clinics in Singapore hospitals where patients with poorly controlled condition are being monitored. In addition, the independent nature of this programme with application of technology will greatly reduce nurses' contact time with patients which accord them more time for those who require more time, for example, those afflicted with diabetes-related complications. This will result in a more efficient use of healthcare resources in the long run. Eventually, this programme will be available for all diabetes patients living in the community.
Feasibility of the Study The research team comprises experienced researchers from different disciplines. The PI has extensive research experience in the area of chronic diseases management and mHealth intervention. Two Co-Is are practised clinicians in diabetes care, they will facilitate the access to potential study participants and oversee the implementation of the project. One Co-I has the expertise in biomedical engineering, mobile App development, and information management. He and his team will be in charge of developing the system. In addition, the preliminary integrative literature review and qualitative patient interviews were performed to inform the development of the content for the mobile app. Through harnessing the technology, the smartphone App based platform can be established to reduce the contact time with patients for the healthcare providers.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Experimental Group | Experimental | Behavioral: nurse-led smartphone-based self-management programmeA six-month nurse-led smartphone-based self-management programme (i.e. NSSMP) will be provided to the participants in the experimental group. |
| Control Group | Active comparator | Behavioral: exiting nurse-led diabetes servicethe patients in the control group will receive the exiting nurse-led diabetes service (i.e. NDS) provided by the hospital |
Who may qualify
- Ages
- 21 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- have confirmed medical diagnosis of type 2 DM;
- are 21 years old and above;
- have blood test result of HbA1c > 8% in the most recent test indicating poor glycemic control;
- possess and able to use smart mobile phone (e.g. Samsung Galaxy, iPhone) in their daily lives; and
- are able to speak and read English or Chinese.
Key exclusion criteria (3 listed)
- have suffered severe complications such as severe stroke, visual impairment, renal failure that interfere with self-care activities;
- have known history of major psychiatric illness;
- have reading and hearing difficulties.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| nurse-led smartphone-based self-management programmeThe participants in the experimental group will undergo nurse-led smartphone-based self-management programme (NSSMP), a 6-month programme comprising an individual education session, and a newly developed smartphone App as a self-help education resource | Behavioural | Experimental Group |
| exiting nurse-led diabetes servicethe patients in the control group will receive the exiting nurse-led diabetes service (i.e. NDS) provided by the hospital | Behavioural | Control Group |
Primary outcome
Self-efficacy: change is being assessed
Time frame: Change from baseline self-efficacy at 6 months
Self-efficacy will be assessed using the General Self-efficacy Scale (GSS), a 10-item questionnaire of the unidimensional measure of one's competence to deal with the challenging events encountered in various life situations
9 secondary outcomes
Diabetes self-care activities: change is being assessed
Time frame: Change from baseline diabetes self-care acitivities at 6 months
Health-related Quality of Life: change is being assessed
Time frame: Change from baseline health-related quality of life at 6 months
Acute Diabetes Complications: change is being assessed
Time frame: Change from baseline acute diabetes complications at 6 months
HbA1c: change is being assessed
Time frame: Change from baseline HbA1c at 6 months
Smoking status: change is being assessed
Time frame: Change from baseline smoking status at 6 months
Alcohol consumption: change is being assessed
Time frame: Change from baseline alcohol consumption at 6 months
Diabetes-related hospital admission
Time frame: at the 6-month of the study period
Visits to the emergency
Time frame: at the 6-month of the study period
Unplanned medical consultation
Time frame: at the 6-month of the study period
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Mar 2017.
- Derived from this study: PubMed 35170786Jiang Y, Ramachandran HJ, Teo JYC, Leong FL, Lim ST, Nguyen HD, Wang W. Effectiveness of a nurse-led smartphone-based self-management programme for people with poorly controlled type 2 diabetes: A randomized controlled trial. J Adv Nurs. 2022 Apr;78(4):1154-1165. doi: 10.1111/jan.15178. Epub 2022 Feb 15.
- Derived from this study: PubMed 28727183Wang W, Seah B, Jiang Y, Lopez V, Tan C, Lim ST, Ren H, Khoo YH. A randomized controlled trial on a nurse-led smartphone-based self-management programme for people with poorly controlled type 2 diabetes: A study protocol. J Adv Nurs. 2018 Jan;74(1):190-200. doi: 10.1111/jan.13394. Epub 2017 Aug 17.
- Individual participant dataSharing planned: No
Related trials for Type2 Diabetes Mellitus
Not yet recruiting
Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Active, not recruiting
Helping Adults With Type 2 Diabetes Use Their Health Data for Healthy Diabetes Self-Management
Type 2 Diabetes Mellitus (T2DM)
Not yet recruiting
Care COMPASS Study
Diabetes Mellitus ( Type 1 and Type 2), Hypertension
Enrolling by invitationObservational study
Personalizing A1c Using Hematologic Indices and CGM for Accurate Diabetes Diagnosis
Type 2 Diabetes
RecruitingObservational study
Investigating the Link Between Advanced Glycation End Products (AGEs) and Muscle Wasting in Sarcobesity
Sarcopenia, Obesity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Wenru P Wang, PhD principal investigator
National University of Singapore
Questions about this trial
What is this clinical trial studying?
A study testing nurse-led smartphone-based self-management programme and exiting nurse-led diabetes service in people with Type2 Diabetes Mellitus, run by National University of Singapore.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 23 Mar 2017. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Wenru P Wang, PhD (65 66011761, nurww@nus.edu.sg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Self-efficacy: change is being assessed (time frame: Change from baseline self-efficacy at 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03088475, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Mar 2017.